FDA
approval
· 2022-06-24
FDA Approved: PHENTERMINE AND TOPIRAMATE — Supplemental Application (Prasco Laboratories)
Summary
The FDA approved a supplemental application from Prasco Laboratories for the combination drug phentermine/topiramate.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PHENTERMINE AND TOPIRAMATE (PHENTERMINE AND TOPIRAMATE)